OVIDOvid Therapeutics Inc.
$2.15+33% 1Y
$2.15
$1.2052 weeks$2.96
Latest close: below its 200-day averageOct 23, 2026what changed →
Is the price fair?
What OVID's price assumes
Ovid Therapeutics Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 117× revenue.
117
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.97
Price / book · as of 2024-Q4
Details›
- Price / bookas of 2024-Q4
- 0.97
- EV / EBIToperating margin −3687%: the multiple describes the denominator
- not meaningful
- Market capitalisation195.3 million shares, counted Aug 11, 2026
- $419M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.